european union

Rentschler doubles cGMP capacity - European Biotechnology
  1. Biotechnology

Rentschler doubles cGMP capacity – European Biotechnology

In the largest expansion in the company’s 150-year history, the Laupheim-headquartered CDMO Rentschler Biopharma SE has launched a new production line at its site in Milford, USA. According to a company spokesperson, the expansion in the main market for biopharmaceuticals doubles Rentschler’s cGMP-compliant production capacity in one fell swoop. Production for a long-standing client at […]
Written by
No more needles - Exvolvo arises with help of Verily and NLC Health
  1. Biotechnology

No more needles – Exvolvo arises with help of Verily and NLC Health

NLC Health Ventures (Amsterdam, The Netherlands), in partnership with Verily, the precision health technology daughter company of Alphabet/Google, will launch Exolvo Biosciences, a pioneering biotech company providing the next-generation solution for biologic drug delivery as oral administration. NLC Health Ventures launches a new early-stage drug delivery company. The venture builder from The Netherlands partners with […]
Written by
ITM gets equity to launch Phase III lead radiopharmaceutical ITM-11
  1. Biotechnology

ITM gets equity to launch Phase III lead radiopharmaceutical ITM-11

ITM Isotope Technologies Munich SE has raised €188m ito boost radiopharma pipeline, contract manufacturing cpacity, and launch ITM-11. Radiopharma conjugate specialist Isotope Technologies Munich SE has raised €188m in an equity financing led by globally active investor Temasek. BlackRock, Qatar Investment Authority (QIA), ATHOS and Carbyne participated in the financing that will be used to […]
Written by
AmphiStar BV secures €6m to expand production
  1. Biotechnology

AmphiStar BV secures €6m to develop manufacturing

Waste primarily based biosurfactants producer Amphistar BV has closed a €6m funding spherical led by the  European Round Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF). The infusion of €6m in new capital from ECBF, Qbic III and FFTF will empower AmphiStar to kickstart industrial biosurfactant manufacturing in collaboration with exterior companions. […]
Written by
New law to speed up clinical trials
  1. Biotechnology

New legislation to hurry up medical trials

With a brand new legislation, the German authorities desires to extend the variety of medical trials carried out in Germany and make the nation primary in Europe once more. The draft Medical Analysis Act (Medizinforschungsgesetz) introduced by Well being Minister Karl Lauterbach in Berlin earlier than Easter is the centrepiece of Germany’s pharmaceutical technique. With […]
Written by
AMR: Partnership set to improve in vivo antibiotics testing
  1. Biotechnology

AMR: Partnership set to improve in vivo antibiotics testing

The Innovative Medicine Initiative 2 JU-funded €25m project COMBINE is joining forces with  CARB-X & CAIRD, iiCON and Pharmacology Discovery Services to improve in vivo antibiotics testing. The development of novel antibiotics is crucial in the fight against antimicrobial resistance (AMR) but has been neglected for decades due to a lack of development incentives. Another […]
Written by
Recordbreaking BIO-Europe in Munich, but: back to 2019
  1. Biotechnology

Recordbreaking BIO-Europe in Munich, but: back to 2019

The 29th BIO-Europe in Munich was able to boast record figures: around 6,000 participants for the first time, over 30,000 partnering meetings for the first time at what was already the largest European partnering event for biotech and pharma. However, many other figures are currently pointing back to 2019. Record figures and a much better […]
Written by
Pierre Fabre SA licences immunotherapy from Atara Biotherapeutics
  1. Biotechnology

Pierre Fabre SA licences immunotherapy from Atara Biotherapeutics

Pierre Fabre Laboratories SA has extended its global partnership with Atara Biotherapeutics, licencing tabelecleucel commercialisation rights for Northern America and beyond. Paris-based Pierre Fabre Laboratories SA already held a licence for the EU-approved tabelecleucel, an allogeneic T cell based second-line treatment of adult and pediatric patients two years of age and older with relapsed or […]
Written by
Cellectis and AstraZeneca in US$2.2bn deal
  1. Biotechnology

Cellectis and AstraZeneca in US$2.2bn deal

AstraZeneca plc has paid French cancer cell therapy developer Cellectis SA US$25m upfront and US$220m in equity in an US$2.2bn R&D deal for up to ten cell and gene therapies. Under the co-development agreement, that includes a US$80m equity investment and an option for a further equity investment of US$140m by AstraZeneca plc into Cellectis […]
Written by

Good Reads

Scientists uncover new way viruses fight back against bacteria

Scientists recreate mouse from gene older than animal life

Published in Nature Communications, an international team of researchers has achieved an unprecedented milestone: the creation of mouse stem cells capable of generating a fully developed mouse using genetic tools from a unicellular organism, with which we share a common ancestor that predates animals. This breakthrough reshapes our understanding of the genetic origins of stem […]
Written by

VU Researchers Publish Study on the Mechanism of CRISPR-Cas “Protein Scissors” in Molecular Cell

CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and functions. Among them, the most studied proteins today are Cas9 and Cas12, also known as DNA or gene ‘scissors’, which have revolutionized the field of genome editing, enabling scientists to […]
Written by

Worlwide

Scientists uncover new way viruses fight back against bacteria

Scientists recreate mouse from gene older than animal life

Published in Nature Communications, an international team of researchers has achieved an unprecedented milestone: the creation of mouse stem cells capable of generating a fully developed mouse using genetic tools from a unicellular organism, with which we share a common ancestor that predates animals. This breakthrough reshapes our understanding of the genetic origins of stem […]
Written by

VU Researchers Publish Study on the Mechanism of CRISPR-Cas “Protein Scissors” in Molecular Cell

CRISPR-Cas systems help to protect bacteria from viruses. Several different types of CRISPR-Cas defense systems are found in bacteria, which differ in their composition and functions. Among them, the most studied proteins today are Cas9 and Cas12, also known as DNA or gene ‘scissors’, which have revolutionized the field of genome editing, enabling scientists to […]
Written by

Visualizing ER-phagy and ER architecture in vivo

ER-phagy is an evolutionarily conserved mechanism crucial for maintaining cellular homeostasis. However, significant gaps persist in our understanding of how ER-phagy and the ER network vary across cell subtypes, tissues, and organs. Furthermore, the pathophysiological relevance of ER-phagy remains poorly elucidated. Addressing these questions requires developing quantifiable methods to visualize ER-phagy and ER architecture in […]
Written by

Trending

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.